Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms ...
In a subgroup analysis of people living with HIV enrolled in PRIOH-1, pritelivir demonstrated superior lesion healing, achieving 61% complete ...
Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitis ...
Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and symptoms, and systemic corticosteroid use or surgery comp ...
Three-phase treatment offers patients with HSV infections an alternative to perpetual antiviral management ROATAN, BAY ...
Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with standard-of-care therapies (investigator’s choice), resulting in an ...
GlobalWafers opened $3.5 bln Texas plant last year Chairwoman upbeat on Taiwan-US trade deal Company is a major supplier to TSMC HSINCHU, Taiwan, Jan 21 (Reuters) - Taiwanese silicon wafer ...
Journal Editorial Report: The week’s best and worst from Bill McGurn, Allysia Finley and Kim Strassel. Photo: Storyblocks/Marcio Jose Sanchez/Associated Press/Heather Ainsworth/Bloomberg News The ...
President Donald Trump’s administration formally launched the second phase of its plan to end the war between Israel and Hamas this week, shifting from a ceasefire framework toward a post-ceasefire ...
WASHINGTON — The White House announced the start of “Phase Two” of President Trump’s Gaza peace process Wednesday — despite Hamas refusing to disarm. The administration entered the new phase ...
The Trump administration on Wednesday announced the launch of the second phase of President Donald Trump’s 20-point peace plan for Gaza, seeking to shore up the fragile ceasefire between Hamas and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results